Strides Pharma Science Ltd
NSE:STAR

Watchlist Manager
Strides Pharma Science Ltd Logo
Strides Pharma Science Ltd
NSE:STAR
Watchlist
Price: 665.1 INR 7.38% Market Closed
Market Cap: 61.3B INR

P/E
Price to Earnings

22.7
Current
-13.8
Median
19.8
Industry
Higher than median
Higher than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
22.7
=
Market Cap
61.1B INR
/
Net Income
2.7B INR
Earnings Growth PEG
IN
Strides Pharma Science Ltd
NSE:STAR
Average P/E: 26.6
22.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
76.3
49%
1.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
17.6
26%
0.7
DK
Novo Nordisk A/S
CSE:NOVO B
18.5
19%
1
CH
Roche Holding AG
SIX:ROG
24.5
32%
0.8
CH
Novartis AG
SIX:NOVN
18.8
16%
1.2
UK
AstraZeneca PLC
LSE:AZN
29.5
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.6
18%
0.6
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -55.5 N/A N/A
FR
Sanofi SA
PAR:SAN
19.7
28%
0.7

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
15.9
2-Years Forward
P/E
12
3-Years Forward
P/E
9.2